Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.

@article{Gill2013ComparisonOT,
  title={Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.},
  author={M Shaffiq Gill and Emma Claire Paish and John Ronan and Andrew R. Green and Ian O. Ellis and Andrew H. S. Lee},
  journal={Applied immunohistochemistry & molecular morphology : AIMM},
  year={2013},
  volume={21 1},
  pages={90-3}
}
AIM Accurate assessment of estrogen receptor (ER) and progesterone receptor (PR) status of breast cancers is essential for selecting patients for endocrine treatment. This study aimed to compare immunohistochemistry for these markers using the pharmDx system and standard methods. METHODS Sections of 203 core biopsies of invasive carcinoma of the breast were stained for ER and PR using the pharmDx system and standard methods. RESULTS Using a cutoff of H score of 10, there was agreement… CONTINUE READING